Kidney Disease News and Research

RSS

Researchers develop a new approach to better understand the biology of polycystic kidney disease

A research team supported by the National Institutes of Health has developed a new approach to better understand the biology of polycystic kidney disease (PKD), an often-life-threatening genetic disorder that affects millions worldwide.

5 Jan 2023

Early intervention key to managing diabetes, cardiorenal, and metabolic diseases

A panel of US-based experts in cardiology, nephrology, endocrinology, and primary care has prepared specific recommendations for early identification and intervention in obesity, diabetes, and other cardiorenal and metabolic diseases. A detailed report on recommended strategies has been published in the Journal of Diabetes and its Complications.

4 Jan 2023

Salk scientists find a system-wide, molecular impact of time-restricted eating in mice

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a hot topic in the wellness industry.

3 Jan 2023

How can we characterize the burden of post-acute sequelae of COVID-19 in the community?

Researchers characterized the burden of post-acute sequelae of coronavirus disease 2019 (COVID-19) [PASC] in community-dwelling individuals.

3 Jan 2023

Japanese study reveals increase in incidence rates of renal replacement therapy attributed to nephrosclerosis

A new Japanese study reveals that the age-standardized incidence rates of end-stage kidney disease (ESKD) requiring renal replacement therapy (RRT) due to chronic glomerulonephritis and diabetic nephropathy has decreased, while rates due to nephrosclerosis have increased considerably between 2006 and 2020.

23 Dec 2022

U.S. counties with more evictions have higher mortality rates, study finds

Mortality rates are higher in U.S. counties where eviction rates are also elevated, and this trend is strongest in areas with higher proportions of Black residents and women, UT Southwestern researchers found.

22 Dec 2022

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

Researchers observe that COVID-19 patients were at an increased risk of developing certain conditions.

21 Dec 2022

Outpatient clinic visits with a nephrologist associated with lower risk of mortality in patients with acute kidney injury

Outpatient clinic visits with a nephrologist and attention to kidney complications and cardiovascular disease were associated with 29% lower risk of mortality compared to standard of care in patients with AKI during recent hospitalization.

16 Dec 2022

Study uncovers new immune target to treat atherosclerosis

For the longest time, clinicians have treated cardiovascular disease by focusing on diabetes and blood pressure control, reducing cholesterol using medications like aspirin and statins.

16 Dec 2022

Revised guidelines for diabetes care

A recent Diabetes Care journal paper summarized the latest recommendations offered to people with diabetes to improve their health and well-being.

15 Dec 2022

Common kidney disease could be treated with existing medicines, new study shows

A serious condition that can cause the kidneys to suddenly stop working could be treated with existing medicines, a new study shows.

14 Dec 2022

The debilitating effects of long-COVID in the U.S.

A new study posted to the preprint server medRxiv* discusses chronic disability due to long COVID in the United States.

14 Dec 2022

$Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction$

Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction

AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for dapagliflozin in Great Britain for the treatment of symptomatic chronic heart failure (HF) in patients with HF and a left ventricular ejection fraction (LVEF) >40%, including HF with mildly reduced ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF).

From AstraZeneca 12 Dec 2022

Aging influences the diagnosis and treatment of heart attacks in patients over age 75

For people ages 75 and older, age-related changes in general health and in the heart and blood vessels require consideration and likely modifications in how heart attacks and heart disease are treated, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

12 Dec 2022

Trial aims to make it easier, convenient for patients to perform health checks and reduce pressure on GPs

A landmark trial aiming to make it easier and more convenient for patients to carry out important health checks and reduce pressure on GPs has been launched in Cornwall.

5 Dec 2022

What is the association between renal function and regular coffee consumption?

Researchers explored the correlation between regular coffee usage and renal function.

2 Dec 2022

Lower frequency of dietary salt associated with reduced risk of heart disease

Adding additional salt to foods at a lower frequency is associated with a reduced risk of heart disease, heart failure and ischemic heart disease, according to a new study published today in the Journal of the American College of Cardiology.

28 Nov 2022

Researchers uncovers a link between D-amino acids and severe viral infection

Just as bricks are key components in constructing a building, molecules known as amino acids are essential components in constructing proteins in the body.

28 Nov 2022

Should older seniors risk major surgery? New research offers guidance

Nearly 1 in 7 older adults die within a year of undergoing major surgery, according to an important new study that sheds much-needed light on the risks seniors face when having invasive procedures.

28 Nov 2022

Among US veterans with COVID-19, few used antivirals or monoclonal antibodies

In a recent study published in the journal JAMA Network, researchers in the United States investigated factors that restricted the use of antivirals directed at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States (US) between January and February 2022.

16 Nov 2022

Kidney Disease News and Research

Researchers develop a new approach to better understand the biology of polycystic kidney disease

Early intervention key to managing diabetes, cardiorenal, and metabolic diseases

Salk scientists find a system-wide, molecular impact of time-restricted eating in mice

How can we characterize the burden of post-acute sequelae of COVID-19 in the community?

Japanese study reveals increase in incidence rates of renal replacement therapy attributed to nephrosclerosis

U.S. counties with more evictions have higher mortality rates, study finds

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

Outpatient clinic visits with a nephrologist associated with lower risk of mortality in patients with acute kidney injury

Study uncovers new immune target to treat atherosclerosis

Revised guidelines for diabetes care

Common kidney disease could be treated with existing medicines, new study shows

The debilitating effects of long-COVID in the U.S.

Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction

Aging influences the diagnosis and treatment of heart attacks in patients over age 75

Trial aims to make it easier, convenient for patients to perform health checks and reduce pressure on GPs

What is the association between renal function and regular coffee consumption?

Lower frequency of dietary salt associated with reduced risk of heart disease

Researchers uncovers a link between D-amino acids and severe viral infection

Should older seniors risk major surgery? New research offers guidance

Among US veterans with COVID-19, few used antivirals or monoclonal antibodies

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News